Citadel Advisors
PHIO icon

Citadel Advisors’s Phio Pharmaceuticals PHIO Stock Holding History

Citadel Advisors’s Portfolio PHIO Stock Details PHIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-44,526
Closed -$80.1K – 15321
2024
Q4 		$80.1K Buy
+44,526
New +$121K ﹤0.01% 11779
2024
Q3 		– Sell
-2,410
Closed -$15.2K – 14975
2024
Q2 		$15.2K Buy
+2,410
New +$15.8K ﹤0.01% 12848
2024
Q1 		– Sell
-3,538
Closed -$24.2K – 15262
2023
Q4 		$24.2K Buy
+3,538
New +$36.4K ﹤0.01% 12458
2022
Q1 		– Sell
-269
Closed -$29K – 14339
2021
Q4 		$29K Buy
269
+18
+7% +$2.86K ﹤0.01% 13488
2021
Q3 		$55K Sell
251
-92
-27% -$19.2K ﹤0.01% 13319
2021
Q2 		$84K Buy
343
+128
+60% +$31.6K ﹤0.01% 13046
2021
Q1 		$62K Buy
+215
New +$71.5K ﹤0.01% 12794
2020
Q4 		– Sell
-113
Closed -$26K – 11375
2020
Q3 		$26K Buy
+113
New +$28.8K ﹤0.01% 9802
2019
Q3 		– Sell
-14
Closed -$33K – 9616
2019
Q2 		$33K Buy
14
+8
+133% +$21K ﹤0.01% 8846
2019
Q1 		$15K Buy
6
+3
+100% +$6.73K ﹤0.01% 9111
2018
Q4 		$7K Buy
+3
New +$7.09K ﹤0.01% 8968
2018
Q1 		– Hold
0
– -$16K – 8656
2017
Q4 		– Hold
0
– – – 7864
2017
Q3 		– Sell
-1
Closed -$34.5K – 7450
2017
Q2 		$28K Buy
+1
New +$37K ﹤0.01% 7223
2016
Q4 		– Hold
0
– -$22K – 7695
2016
Q3 		– Hold
0
– – – 7022
2016
Q2 		– Hold
0
– -$25K – 7253
2016
Q1 		– Hold
0
– – – 6416
2015
Q4 		– Hold
0
– – – 8005
2015
Q1 		– Hold
0
– -$19K – 8770
2014
Q4 		– Hold
0
– – – 7850
2014
Q3 		– Hold
0
– – – 7276
2014
Q2 		– Hold
0
– -$53K – 8215
2014
Q1 		– Hold
0
– – – 6743

Other funds holding PHIO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $49B AUM 17.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

Citadel Advisors's PHIO Position: Q1 2025 in Review

Citadel Advisors sold out of Phio Pharmaceuticals (PHIO) in Q1 2025, closing a stake of 44,526 shares — an estimated $80.1K sold.

Citadel Advisors first reported a position in PHIO in Q2 2017 and held it in 12 quarters. The position peaked at $84K in Q2 2021. 11 funds tracked by Wall St. Rank hold PHIO as of Q1 2025.

  • Citadel Advisors reported no remaining Phio Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Citadel Advisors sold 44,526 Phio Pharmaceuticals shares in Q1 2025, an estimated $80.1K.
  • Citadel Advisors first reported a position in Phio Pharmaceuticals in Q2 2017 and held it in 12 quarters.
  • Citadel Advisors's Phio Pharmaceuticals position peaked at $84K in Q2 2021.
  • 11 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q1 2025.

Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.